Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up

Tarih
2011
Yazar
Smith, Ian
Mauriac, Louis
Lang, Istvan
Forbes, John F.
Thuerlimann, Beat
Regan, Meredith M.
Neven, Patrick
Giobbie-Hurder, Anita
Goldhirsch, Aron
Ejlertsen, Bent
Coates, Alan S.
Gelber, Richard D.
Price, Karen N.
Rabaglio, Manuela
Wardley, Andrew
Üst veri
Tüm öğe kaydını göster
Özet
Background Postmenopausal women with hormone receptor-positive early breast cancer have persistent, long-term risk of breast-cancer recurrence and death. Therefore, trials assessing endocrine therapies for this patient population need extended follow-up. We present an update of efficacy outcomes in the Breast International Group (BIG) 1-98 study at 8.1 years median follow-up.
Bağlantı
http://hdl.handle.net/20.500.12627/178755
https://doi.org/10.1016/s1470-2045(11)70270-4
Koleksiyonlar